Heart Failure Clinical Trial
DORAYA-HF Early Feasibility Study
Summary
The study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.
Eligibility Criteria
Inclusion Criteria:
Subject is hospitalized with primary diagnosis of ADHF.
N-terminal-pro-brain natriuretic peptide (NT-proBNP) ≥1,000 pg/m or BNP≥250 pg/mL.
Evidence of fluid overload.
Subject insufficiently responds to IV diuretic therapy
Exclusion Criteria:
Systolic blood pressure < 90 mmHg at the time of screening.
Acute myocardial infarction or acute coronary syndrome or cardiogenic shock or pleurocentesis within past 14 days or cardiovascular intervention within past 14 days.
Complex congenital heart disease (e.g., Tetralogy of Fallot subjects, single ventricle physiology).
Known active myocarditis, hypertrophic obstructive cardiomyopathy, infiltrative cardiomyopathy (e.g., amyloidosis), constrictive pericarditis or cardiac tamponade.
Severe Aortic valvular disorder (i.e., hemodynamically relevant valvular diseases such as severe stenosis severe regurgitation) or Severe mitral disease with planned intervention.
Evidence of active systemic infection documented by either one of the following: fever >38°C/100°F, or ongoing uncontrolled infection (i.e., inflammatory parameters not decreasing despite > 48 hours of antibiotic treatment).
Moribund subject or subject with severe or deteriorating damage in more than 3 critical body systems, based on investigator's clinical judgement.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 7 Locations for this study
Davenport Iowa, 52807, United States More Info
Principal Investigator
Detroit Michigan, 48202, United States More Info
Principal Investigator
Saint Louis Missouri, 63136, United States More Info
Contact
Principal Investigator
New York New York, 10032, United States More Info
Principal Investigator
Sub-Investigator
New York New York, 10461, United States More Info
Principal Investigator
Sub-Investigator
Cincinnati Ohio, 45219, United States More Info
Contact
Principal Investigator
Sub-Investigator
Cleveland Ohio, 44195, United States More Info
Contact
Principal Investigator
Sub-Investigator
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.